Parkinson’s Tremor Treatment: What Can Reduce Shaking?

Parkinson’s tremor often improves with dopaminergic medication, particularly levodopa. When shaking remains troublesome despite appropriate medication, specialist procedures may be considered, while assistive strategies can help with tremor that continues to affect daily tasks.
Table of Contents
Parkinson’s Tremor Treatment

Treatment does not always eliminate shaking completely. The goal is usually to reduce tremor enough to improve movement, comfort and daily function while balancing treatment risks and side effects.

The right approach depends on how severe the tremor is, how it responds to medication and how much it interferes with activities such as eating, drinking, writing or dressing.

Which Medications Can Reduce Parkinson’s Tremor?

Levodopa is usually the main medication used to treat Parkinson’s motor symptoms and is often effective for tremor, although some people have a weaker or incomplete tremor response.

Levodopa is converted into dopamine in the brain and helps compensate for the dopamine loss associated with Parkinson’s disease. For many people, the same treatment that improves slowness and rigidity also reduces resting tremor.

However, tremor does not always respond in the same way as other Parkinson’s symptoms. A person may experience clear improvement in stiffness or movement speed while continuing to have noticeable shaking.

Persistent tremor does not mean levodopa has failed. Clinicians consider whether the medication has been appropriately adjusted, whether tremor changes between doses and whether other Parkinson’s symptoms are responding before moving to other options.

Medication choice depends not only on tremor severity, but also on age, cognitive status, other Parkinson’s symptoms and how the tremor responds across the medication cycle.

Read more: GyroGlove™ vs Medication and Surgery for Hand Tremors: What’s the Difference?

What If Medication Does Not Control Parkinson’s Tremor?

When Parkinson’s tremor remains functionally disruptive despite appropriately managed medication, advanced treatments such as deep brain stimulation or focused ultrasound may be considered. Botulinum toxin has a more selective role for certain tremor patterns.

These options differ in how they work, whether treatment can be adjusted later and which patients are appropriate candidates.

Can Deep Brain Stimulation Reduce Parkinson’s Tremor?

Yes. Deep brain stimulation can substantially reduce Parkinson’s tremor in appropriately selected patients, including some people whose tremor responds poorly to medication.

DBS involves surgically implanting electrodes in specific movement-related areas of the brain. These electrodes are connected to a programmable device that delivers electrical stimulation to modify abnormal brain activity.

An important advantage is that DBS can be adjusted after surgery. Stimulation settings can be changed as symptoms or treatment needs evolve.

DBS is generally considered when Parkinson’s movement symptoms remain difficult to control with medication, when medication produces troublesome fluctuations or side effects, or when disabling tremor persists despite otherwise appropriate medical treatment. Tremor is somewhat unusual among Parkinson’s symptoms because it may improve with DBS even when its response to levodopa has been limited.

DBS is still brain surgery and requires careful patient selection. A movement disorders team considers factors such as diagnosis, symptom pattern, medication response, cognition, general health and treatment goals before recommending it.

Can Focused Ultrasound Reduce Parkinson’s Tremor?

Yes. MRI-guided focused ultrasound can reduce medication-resistant Parkinson’s tremor in selected patients without implanting a device.

Focused ultrasound directs sound-wave energy toward a precisely selected brain target. The energy heats and permanently alters a small area of tissue involved in abnormal movement signaling.

This creates an important difference from DBS:

  • DBS modulates brain activity using an implanted, programmable system.
  • Focused ultrasound creates a permanent lesion and cannot be adjusted afterward.

Focused ultrasound does not require implanted electrodes or a pulse generator, but that does not make it a risk-free alternative. Possible complications include balance problems, weakness, numbness, speech or swallowing difficulties, and some effects can persist.

Can Botox Help Parkinson’s Tremor?

Botulinum toxin may reduce troublesome hand tremor in selected people with Parkinson’s, but it is a specialist option rather than a standard first-line treatment.

Unlike levodopa, DBS or focused ultrasound, botulinum toxin acts on selected muscles involved in the visible tremor. The injections temporarily weaken targeted muscle activity, which can reduce shaking when the correct muscles and doses are chosen.

The evidence is promising but more limited than for established Parkinson’s treatments. If the wrong muscles are targeted or the dose is too high, reducing tremor can come at the cost of grip strength or hand dexterity. Individualized injection planning, often using electromyography or movement analysis, is therefore important.

Botulinum toxin is most relevant when tremor is localized and functionally troublesome, particularly when conventional treatment has not provided adequate control or when other advanced procedures are not suitable.

What Can Help When Parkinson’s Tremor Still Affects Daily Activities?

When tremor remains despite medical treatment, occupational strategies and assistive devices can help reduce its impact on daily activities even if they do not treat the underlying Parkinson’s disease.

A treatment can reduce tremor severity, while a functional aid addresses what the remaining tremor makes difficult.

For example, persistent hand tremor may interfere with:

  • bringing a cup to the mouth without spilling;
  • using utensils accurately;
  • writing legibly;
  • grooming;
  • holding a phone;
  • handling small objects.

An occupational therapist can help identify practical adaptations based on which tasks are most difficult. Options may include modified utensils, drinking aids, writing tools, changes in task technique or other assistive equipment.

From a hand-stabilization perspective, visible tremor severity and functional difficulty are not always the same thing. A relatively modest tremor can have a large effect on tasks requiring precise control, while a more visible tremor may interfere less with some other activities.

GyroGear develops wearable technology specifically for people living with hand tremor. GyroGlove™ is a non-invasive wearable designed to assist with hand stabilization and may help support certain daily activities for suitable users whose tremor remains functionally disruptive. It is not a treatment for Parkinson’s disease and does not replace medication, DBS, focused ultrasound or medical care.

Learn more:

Parkinson’s tremor treatment therefore does not follow a single pathway. Medication, particularly levodopa, is usually the starting point; advanced treatments may be considered when shaking remains difficult to control; and functional support can help address the daily impact of tremor that remains.

The most appropriate approach depends on how much the tremor interferes with daily life, how well it responds to medication and whether the potential benefit of an advanced treatment outweighs its risks.

Picture of GyroGear Team
GyroGear Team

GyroGear team provides clinical perspective and review for educational content related to tremor and daily function.

The team includes professionals with backgrounds in neurology, rehabilitation, and patient-centered care. Their role is to help ensure that information is accurate, clear, and aligned with real-world patient needs.

The team contributes to reviewing content on conditions such as Essential Tremor and Parkinson’s disease, with a focus on practical challenges individuals face in everyday life.

Leave a Reply

RELATED ARTICLES

Share your details to find out about GyroGlove screening availability near you.

*GyroGlove costs USD5,899, with free shipping included. Applicable taxes are additional. HSA/FSA funds may be used, subject to eligibility. For information about VA access, speak with our team. GyroGlove is currently not covered by Medicare or private health insurance.

Start a Conversation